Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life. Issue 9 (2nd September 2021)

• Record Type: Journal Article
• Authors: Hsieh, Chia-Chen; Ho, Chao-Chi; Lin, Zhong-Zhe; Yu, Chong-Jen; Jow, Guey-Mei; Huang, Feng-Ying; Shih, Jin-Yuan; Hsiao, Fei-Hsiu
• Is Part Of: Psychology & health. Volume 36:Issue 9(2021)
• Page Start: 1102
• Page End: 1114
• Publication Date: 2021-09-02
• Subjects: trait mindfulness -- depressive symptoms -- function -- symptom distress -- meaning in illness; Clinical health psychology -- Periodicals; Attitude to Health -- Periodicals; Public Opinion -- Periodicals; Psychology -- Periodicals; 150
• DOI: 10.1080/08870446.2020.1825713
• Languages: English
• ISSNs: 0887-0446

Abstract

Abstract: Objective: The present study examined the potential mediating influences of meaning in life and quality of life in the relationship of trait mindfulness and depressive symptoms in lung cancer patients. Design: We adopted a cross-sectional design studying a sample of patients with non-small cell lung cancer, aged 20–65 years, and receiving cancer treatments or follow-up care. Main Outcome Measures: The outcome measures included Beck Depression Inventory-II, European Organisation for Research and Treatment of Cancer Core Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and lung cancer specific complementary measure (EORTC QLQ-LC13), Five Facet Mindfulness Questionnaire, and the meaning in life questionnaire. Results: Among 116 lung cancer patients, 26.72% of them had clinically significant depressive symptoms. The presence of meaning, quality of life (QOL) functioning and symptom distress mediated the relationship of trait mindfulness and depressive symptoms. Multiple mediation analyses found that the presence of meaning in life was the main mediator. Conclusion: The reductions of depressive symptoms might be related to trait mindfulness enhancing lung cancer patients' perceptions of meaning in life. A mindfulness program has the potential to improve depressive symptoms in people with lung cancer.